Products

S.NO	API	CAS NO	THERAPEUTIC USE	pharmacopoeia	Docs Available
1	Ezetimibe	163222-33-1	Anti-hyperlipidaemic	IP/USP	DMF
2	Dorzolamide Hydrochloride	130693-82-2	Glaucoma	IP/EP/USP	CEP Applied
3	Bilastine	202189-78-4	Anti Histamine	IH/IP	WHO GMP
4	Rivaroxaban	366789-02-8	Anticoagulant	IP/EP/USP	Under Development
5	Suvorexant	1030377-33-3	Insomnia	IH	Under Development

S.NO	INTERMEDIATE NAME	CAS NO	Code	STATUS
EZETIMIBE
1	(S)-(+)-4-Phenyl-2-oxazolidinone	99395-88-7	SPOZ	Reagent & commercialized
2	4-(4-Fluorobenzoyl)butyric acid	149437-76-3	EZE-S1	Key starting material & commercialized
3	(4S)-3-[5-(4-Fluorophenyl)-1,5-dioxopenyl]-4-phenyl-2-oxazolidinone	189028-93-1	EZE-2	Intermediate & commercialized
4	4-[[(4-Fluorophenyl) imino]methyl]-phenol	3382-63-6	EZE-S2	Key starting material & commercialized
5	(4S)-3-[(2R,5S)-5-(4-Fluorophenyl)-2-[(S)-[4-fluorophenyl)amino](4-hydroxyphenyl)methyl]-5-hydroxypentanoyl]-4-phenyl-1,3-oxazolidin-2-one	1185883-40-2	EZE-5	Intermediate & commercialized
DORZOLAMIDE HYDROCHLORIDE
6	(3S)-3-(2-Thienylthio) butanoic acid	133359-80-5	DOR-1	Advanced Key starting material & commercialized (100% Indigenous)
7	(6S)-4-oxo-6-methyl-5,6-dihydro-4H--thieno[2,3-b]thiopyran-2-sulfonamide	1383784-43-7	DTS	Intermediate & commercialized (100% Indigenous)
8	(S)-6-Methyl-5,6-dihydro-4H-thieno[2,3-b] thiopyran-4-one	147086-79-1	DOR-2A	Key starting material & commercialized (100% Indigenous)
9	(6S)-5,6-dihydro-6-methyl-4H-thieno[2,3-b] thiopyran-4-one	148719-91-9	DOR-2	Key starting material & commercialized (100% Indigenous)
10	(4R,6S)-5,6-Dihydro-4-hydroxy-6-methylthieno [2,3-b] thiopyran-7,7-dioxide	147128-77-6	DOZ-S1	Key starting material & commercialized (100% Indigenous)
11	(4S,6S)-5,6-dihydro-4-hydroxy-6-methylthieno[2,3-b]thiopyran-7,7-dioxide	147086-81-5	DZM-S1	Key starting material & commercialized (100% Indigenous)
12	(4S,6S)-4-(Acetylamino)-5,6-dihydro-6-methyl-4H-thieno[2,3-b]-thiopyran-7,7-dioxide	147086-83-7	DZM-1	Advanced Intermediate & commercialized (100% Indigenous)
13	N-[(4S,6S)-6-Methyl-7,7-dioxo-5,6-dihydro-4H-thieno[2,3-b] thiopyran-4-yl] acetamide	147086-83-7	DOZ-1	Advanced Intermediate & commercialized (100% Indigenous)
14	N-[(4S,6S)-2-(Aminosulfonyl)-5,6-dihydro-6-methyl-7,7-dioxido-4H-thieno[2,3-b] thiopyran-4-yl] acetamide	147200-03-1	DOZ-4	Advanced Intermediate & commercialized (100% Indigenous)
BILASTINE
15	Methyl-2-(4-(2-chloroethyl)phenyl-2-methylpropanoate	1181267-33-3	BIL-S1	Key starting material & commercialized (100% Indigenous)
16	1-(2-Ethoxyethyl)2-(piperidin-4-yl)1H-benzo[d]imidazole hydrochloride	1841081-72-8	BIL-S2	Key starting material & commercialized (100% Indigenous)
17	Methyl2-(4-(2-(4-(1-(2-ethoxyethyl)-1H-benzo[d]imidazol-2-yl) piperidin-1-yl) ethyl) phenyl)-2-methylpropanoate (Bilastine Ester)	1181267-38-8	Bil-Ester	Advanced Intermediate & commercialized (100% Indigenous)
DABIGATRAN ETEXILATE MESYLATE
18	3-[3-Amino-4-(Methylamino)-N-(2-Pyridyl) benzamido)propionic acid ethyl ester	212322-56-0	DAB-S1	Key starting material & commercialized (100% Indigenous)
19	2-(4-Cyanophenylamino) acetic acid	42288-26-6	DAB-S2	Key starting material & commercialized (100% Indigenous)
20	Ethyl-3-{[(2-{[(4-(carbamimidoyl)phenyl)amino]methyl}- 1-methyl-1H-benzimidazol-5-yl)carbonyl]pyridin-2- yl)amino)propanoate hydrochloride	211914-50-0	DAB	Advanced Intermediate (100% Indigenous)
rivaroxaban
21	4-(4-Aminophenyl) morpholin-3-one	438056-69-0	RIV-S1	Key starting material & commercialized (100% Indigenous)
22	(S)-(+)-N-(2,3-Epoxypropyl)phthalimide	161596-47-0	RIV-S2	Key starting material & commercialized (100% Indigenous)
23	5-Chlorothiophene-2-carboxylic acid	24065-33-6	RIV-S3	Key starting material & commercialized (100% Indigenous)
24	2-{(2R)-2-hydroxy-3-[4-(3-oxomorpholin-4-yl)anilino]propyl}-1H-isoindole-1,3(2H)-dione	446292-08-6	RIV-1	Advanced Intermediate & Commercialized (100% Indigenous)
25	4-{4-[(5S)-5-(aminomethyl)-2-oxo-1,3-oxazolidin-3-yl]phenyl}morpholin-3-one hydrochloride	898543-06-1	RIV-3	Advanced Intermediate & Commercialized (100% Indigenous)
suvorexant
26	5-chloro-1,3-benzoxazole-2-thiol	22876-19-3	DBX-I	Advanced Intermediate & Commercialized (100% Indigenous)
27	2-(5-Chlorobenzo[d]oxazol-2-yl amino)ethanol	1356342-15-8	CBA	Advanced Intermediate (100% Indigenous)
28	Methane sulfonic acid 2-[5-chloro benzooxazol-2-yl-(3-oxobutyl)amino]ethyl ester	1383717-11-0	MCBE	Advanced Intermediate (100% Indigenous)
29	(R)-5-Chloro-2-(5-methyl-1,4-diazepan-1-yl)benzo[d]oxazole	1266975-27-2	CMBD Free Base	Advanced Intermediate (100% Indigenous)
30	(R)-5-Chloro-2-(5-methyl-1,4-diazepan-1-yl)benzo[d]oxazole Hydrochloride	1266664-66-7	CMBD	Advanced Intermediate (100% Indigenous)
31	(R)-Benzyl-5-methyl-1,4-diazepane-1-carboxylate	1001401-60-0	SUV-S1	Advanced Intermediate (100% Indigenous)
32	5-Methyl-2-(2H-1,2,3-triazole-2-yl) benzoic acid	956317-36-5	SUV-S2	Advanced Intermediate (100% Indigenous)
33	2,5-Dichloro-1,3-Benzoxazole	3621-81-6	SUV-S3	Advanced Intermediate & Commercialized (100% Indigenous)
34	Benzyl (5R)-5-methyl-4-[5-methyl-2-(2H-1,2,3-triazol-2-yl)benzoyl]-1,4-diazepane-1-carboxylate	1030377-31-1	SUV-1	Advanced Intermediate & Commercialized (100% Indigenous)
35	(7R)-7-Methyl-1-[5-methyl-2-(2H-1,2,3-triazol-2-yl)benzoyl]-1,4-diazepane	1030377-32-2	SUV-2	Advanced Intermediate & Commercialized (100% Indigenous)
bosentan
36	Dimethyl-2-chloromalonate	28868-76-0	2-CDM	Key starting material & commercialized (100% Indigenous)
CHIRAL RESOLVING AGENT
37	R-(-)-N-(3,5-Dinitrobenzoyl)-α-Phenylglycine	74927-72-3	DPG	Advanced Intermediate & Commercialized (100% Indigenous)
alogliptin/lingliptin/trelagliptin
38	(R)-3-Aminopiperidine Dihydrochloride	334618-23-4	APD	Advanced Intermediate & Commercialized (100% Indigenous)
brinzolamide
39	(S)-3,4-Dihydro-4-hydroxy-2-(3-methoxypropyl)-2H-thieno[3,2-e]-1,2-thiazine-6-sulfonamide 1,1-dioxide	154127-42-1	HMDTS	Advanced Intermediate (100% Indigenous)
sitagliptin
40	(S)-(+)-2-Phenylglycinol	20989-17-7	2-SPG	Chiral Reagent & Commercialized (100% Indigenous)

Products

Our Philosophy

Manufacturing Site Location